<DOC>
	<DOCNO>NCT00000789</DOCNO>
	<brief_summary>PRIMARY : To compare relative safety tolerance oral zidovudine ( AZT ) versus oral stavudine ( d4T ) symptomatic HIV-infected child . SECONDARY : To compare clinical , virologic , immunologic response two treatment group , obtain pharmacokinetic data drug . At present , AZT consider drug choice initial treatment child HIV infection , although disease progression drug intolerance associate long-term use . In preliminary study child , d4T , another HIV inhibitor , well tolerate , although optimum dose determine .</brief_summary>
	<brief_title>A Randomized , Comparative Trial Zidovudine ( AZT ) Versus 2',3'-Didehydro-3'-Deoxythymidine ( Stavudine ; d4T ) Children With HIV Infection</brief_title>
	<detailed_description>At present , AZT consider drug choice initial treatment child HIV infection , although disease progression drug intolerance associate long-term use . In preliminary study child , d4T , another HIV inhibitor , well tolerate , although optimum dose determine . Patients randomize receive either oral AZT oral d4T . Treatment continue last patient enrol receive 52 week therapy , study terminate .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Recommended : PCP prophylaxis . Allowed : Immunoglobulin . Erythropoietin , GCSF , GMCSF . Corticosteroids . Ethionamide isoniazid TB alternative available . Pyridoxine ( 50 mg/day ) vitamin supplement . Patients must : Symptomatic HIV infection . No 6 week prior antiretroviral immunomodulator therapy ( steroid IVIG ) . Consent parent guardian . NOTE : Coenrollment another ACTG protocol involve antiretroviral therapy permit . Prior Medication : Allowed : Maternal immunomodulator antiretroviral therapy ( include pregnancy ) . Antiretroviral therapy prior 2 month . Up 6 week prior antiretroviral therapy specific immunomodulator therapy ( corticosteroid IVIG ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Current grade 3 bad neuropathy / low motor neuropathy . Other grade 3 bad clinical laboratory toxicity . Known intolerance either AZT d4T . Concurrent Medication : Excluded : Chemotherapy active malignancy . Patients follow prior condition exclude : History grade 3 bad neuropathy/lower motor neuropathy . Prior Medication : Excluded : More 6 week prior antiretroviral immunomodulator therapy . Antiretroviral immunomodulator therapy within 7 day prior study entry . Ongoing drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Stavudine</keyword>
</DOC>